Journal
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
Volume 19, Issue 1, Pages 63-72Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/S0885-3924(99)00134-7
Keywords
pain; children; sickle cell disease; comfort; and analgesics
Funding
- NATIONAL INSTITUTE OF NURSING RESEARCH [R15NR003352] Funding Source: NIH RePORTER
- NINR NIH HHS [7 R15 NR03352-02] Funding Source: Medline
Ask authors/readers for more resources
The effectiveness of analgesia during sickle cell crisis was examined in this descriptive, exploratory study. Pain scores (using the African-American Oucher and the Adolescent Pediatric Pain Tool) and analgesics administered were examined during a 2-hour observation/interview in the hospital while children/adolescents with sickle cell disease (SCD) experienced a vaso-occlusive episode (VOE). A convenience sample of twenty-one 6- to 16-year olds with SCD was included. Evidence indicated that 15 of the 21 children in the sample were in moderate to severe pain during their interviews, indicating that the analgesics did not effectively control their pain. Most participants (17) had received nalbuphine as the primary analgesic by intravenous infusion drip and/or patient-controlled analgesia pump. Many reasons were identified for the inadequate analgesia. The results suggested that the pain of SCD is very complex, requiring continuous adjustment of comfort measures, especially analgesics. More research is needed to examine pain control in children with SCD. (C) U.S. Cancer Pain Relief Committee, 2000.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available